During the past decade, Abington Reproductive Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Abington Reproductive Medicine" are "Infertility" (3 trials), "Infertility, Female" (1 trials) and "Progesterone Supplementation in Women Undergoing ART" (1 trials). Many other conditions were trialed in "Abington Reproductive Medicine" in a lesser frequency.

Most popular intervention types in "Abington Reproductive Medicine" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Follitropin delta" (2 trials), "Placebo" (2 trials), "AFOLIA" (1 trials), "Gonal-f® RFF" (1 trials) and "MENOPUR powder and solvent for solution for injection, 75 IU" (1 trials). Other intervention names were less common.

The vast majority of trials in "Abington Reproductive Medicine" are 5 trials for "Female" genders.

Currently, there are NaN active trials in "Abington Reproductive Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Abington Reproductive Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Abington Reproductive Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".